pGL2-MCT2Prom2.5
(Plasmid
#87351)
-
PurposeHuman monocarboxylate transporter 2 (MCT2) promoter 2.5 kbp
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 87351 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL2
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 5598
- Total vector size (bp) 8030
-
Vector typeMammalian Expression, Bacterial Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable ; E. coli SURE for propagation, E. coli SCS110 for reporter studies
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMCT2
-
Alt nameSLC16A7
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2432
-
Entrez GeneSLC16A7 (a.k.a. MCT2)
- Promoter 2.5 kbp proximal promoter of human MCT2 (nested deletion construct)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (destroyed during cloning)
- 3′ cloning site HinDIII (not destroyed)
- 5′ sequencing primer GL primer 1
- 3′ sequencing primer GL primer 2 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
A methylation deficient E. coli strain such as SCS110 is preferred to prepare plasmid DNA for mammalian cell transfection to reduce affects of prokaryotic methylation patterns on promoter activity.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGL2-MCT2Prom2.5 was a gift from Saroj Mathupala (Addgene plasmid # 87351 ; http://n2t.net/addgene:87351 ; RRID:Addgene_87351) -
For your References section:
pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma. Caruso JP, Koch BJ, Benson PD, Varughese E, Monterey MD, Lee AE, Dave AM, Kiousis S, Sloan AE, Mathupala SP. Neoplasia. 2017 Jan 13;19(2):121-134. doi: 10.1016/j.neo.2016.12.011. 10.1016/j.neo.2016.12.011 PubMed 28092823